CAMBRIDGE, Mass., March 28, 2024 /PRNewswire/ -- XtalPi Inc., a
leading global technology company in integrating artificial
intelligence (AI) and robotics to advance the discovery of
groundbreaking medicine and innovative materials, announced today
the launch of its proprietary comprehensive solid form discovery
and selection platform, XtalGazer. This advanced platform aims to
significantly improve the polymorph selection process for the
pharmaceutical industry by integrating AI- and automation-powered
experimental and computational approaches.
XtalGazer provides a total solution for delivering high-quality
polymorph screening and selection methods to expedite drug
development and mitigate risks. It represents a paradigm shift in
solid-state research, moving from the traditional trial-and-error
approach to a data-driven, design-led methodology. The platform
provides an expansive suite of foundational tools to accelerate
polymorph discovery, characterization, and selection process,
empowering pharmaceutical companies to conduct thorough research
with less active pharmaceutical ingredient (API) in shorter
development cycles.
A key component of XtalGazer is XtalCSP, a crystal structure
prediction platform to perform global searches of crystal
structures for target molecules and the other optional components
in the corresponding searching space, offering a deep insight into
possible stable forms. Furthermore, crystallization strategy
recommendations will provide AI-backed experimental design to help
avoid human bias. XtalGazer also utilizes MicroED to rapidly
elucidate crystal structures from powder samples, reducing the need
for growing single crystals.
XtalPi's launch of XtalGazer marks another significant step in
the company's ongoing exploration of solid-state research. From
crystal structure prediction platforms being one of the first
products to launch at XtalPi, to today's comprehensive polymorph
selection platform, XtalPi will keep fulfilling its promise to
solving challenging problems in this space. XtalPi will continue to
deliver faster, more accurate, and more comprehensive approaches to
building an ecosystem for the R&D process in solid-state,
pre-formulation and crystallization.
For more information about XtalPi, please visit
www.xtalpi.com.
About XtalPi:
XtalPi is an innovative technology company powered by artificial
intelligence (AI) and robotics. Founded in 2015 on the MIT campus, XtalPi is dedicated to driving
intelligent and digital transformation in the life science and new
materials industries. With tightly interwoven quantum physics, AI,
cloud computing, and large-scale clusters of robotic workstations,
XtalPi offers a range of technology solutions, services, and
products to accelerate and empower innovation for biopharmaceutical
and new materials companies worldwide.
Media Contact:
Vivienne Shen
vivienne.shen@xtalpi.com
Logo -
https://mma.prnewswire.com/media/632519/XtalPi_Logo.jpg
View original
content:https://www.prnewswire.co.uk/news-releases/xtalpi-unveils-xtalgazer-a-comprehensive-ai-driven-polymorph-selection-platform-302102794.html